UBS Group AG - CELLECTAR BIOSCIENCES INC ownership

CELLECTAR BIOSCIENCES INC's ticker is CLRB and the CUSIP is 15117F500. A total of 1 filers reported holding CELLECTAR BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CELLECTAR BIOSCIENCES INC
ValueSharesWeighting
Q2 2022$16,000
+45.5%
39,642
+140.3%
0.00%
Q1 2022$11,000
-67.6%
16,500
-68.2%
0.00%
Q4 2021$34,000
+209.1%
51,958
+351.8%
0.00%
Q3 2021$11,000
-21.4%
11,5000.0%0.00%
Q2 2021$14,000
+366.7%
11,500
+475.0%
0.00%
Q1 2021$3,0000.0%2,000
+36.5%
0.00%
Q4 2020$3,000
+200.0%
1,465
+27.9%
0.00%
Q2 2020$1,0000.0%1,145
+89.9%
0.00%
Q1 2020$1,000
-88.9%
603
-89.4%
0.00%
Q4 2018$9,000
+12.5%
5,696
+124.2%
0.00%
Q3 2018$8,0002,5410.00%
Other shareholders
CELLECTAR BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 193,510$230,276,0000.72%
Consonance Capital Management LP 3,913,000$4,656,0000.56%
ACT CAPITAL MANAGEMENT, LLC 217,500$259,0000.13%
FNY Investment Advisers, LLC 220,321$262,0000.10%
SABBY MANAGEMENT, LLC 426,561$508,0000.07%
GSA CAPITAL PARTNERS LLP 297,653$354,0000.04%
Boxer Capital, LLC 920,000$1,095,0000.04%
Maven Securities LTD 650,000$793,0000.03%
Sterneck Capital Management, LLC 30,000$34,0000.02%
1900 WEALTH MANAGEMENT LLC 60,000$71,0000.01%
View complete list of CELLECTAR BIOSCIENCES INC shareholders